Research.Patient.info
Non-small Cell Lung Cancer research hub
2 indexed studies · 2 currently recruiting
- recruitingNA
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
This study looks at why a lung cancer treatment, amivantamab, stops working for some patients with a specific type of lung cancer (NSCLC with EGFR exon 20 insertion). We collect blood and tissue samples to understand these reasons better.
France - recruiting
Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer
This study looks at how well a treatment combining chemotherapy and amivantamab works for advanced lung cancer with specific gene changes. It helps us understand real-life results and safety for people already receiving this treatment through early access programs.
France